Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Chord Energy heads into its November 4 earnings with an unusual split: sell-side analysts have been upgrading targets in a cluster this week, short sellers have rebuilt positions by more than 9% over the past seven days, and the stock has bounced 6.5% to $146.51, recovering much of the ground it lost last month.
The analyst activity is the freshest signal on the tape. This week alone, Wells Fargo trimmed its target by $1 to $174 while holding Overweight, and Truist raised to $195 from $180 while keeping its Buy. That follows UBS lifting its target twice in the past month, and Mizuho nudging higher to $179. The direction of travel is constructive: targets are clustering in the $174 to $195 range, well above the current price, against a mean target of $176. The one dissenting voice remains Jefferies, which holds its price at $150 with a Hold, matching Citi's neutral stance at the same level. The EV/EBITDA multiple stands at 3.3x on a trailing basis, and the stock trades below book value at 0.88x. For bulls, the argument is a 1.3 million net-acre Williston position, a pending $550 million Marcellus asset sale, and an estimated 18.6% free cash flow yield in 2026. Bears point to single-basin concentration risk and near-term production softness, with Q1 expected to be the output trough.
Short positioning has moved materially since the October 8 note, which described shorts tentatively rebuilding. The rebuild has accelerated. Short interest rose another 9.1% over the past week to 7.1% of the free float, and is up nearly 29% over the past 30 days. That is a meaningful re-accumulation. Yet the borrow market is under no stress. Availability is deep at roughly 1,488%, meaning there are around fifteen shares available to lend for every one currently borrowed. Cost to borrow is running at 0.39%, near its recent floor. The short score has edged up to 49.1 from around 46.3 a fortnight ago, still mid-range. This looks like directional positioning ahead of the earnings event rather than a crowded, conviction-heavy squeeze setup.
Options tell a calmer story than the short book. The put/call ratio is 0.61, just below its 20-day average of 0.64, and the z-score is mildly negative at minus 0.47. That compares to readings above 0.86 in early September, when hedging demand was much heavier. The shift is notable: over six weeks, options positioning has rotated from defensive to roughly neutral, even as short interest climbed. The two signals are pulling in opposite directions.
The insider picture from the October 8 note is unchanged in direction. The 90-day net disposals remain at roughly 47,700 shares worth just under $6.9 million, with no open-market purchases on the register. CEO Daniel Brown sold in late August at prices around $150 to $152. Director Samantha McKinney followed in September. None of those trades were filed under a 10b5-1 pre-arranged plan. The stock has since recovered to $146.51, closing much of the gap to the prices those insiders received. On the institutional side, Invesco added 876,000 shares in the latest reported period, and Dimensional and American Century both added meaningfully. BlackRock holds 12.9% of shares outstanding as the largest holder. No 13D activist is on the register; all disclosed positions are passive 13G filings, with Key Group Long Term Investments having reduced below 5%.
Peer E&P names had a strong week. SM Energy rose nearly 10%, Permian Resources gained 8.5%, and Ovintiv was up 8.4%. CHRD's 6.5% move kept pace with the group but trailed the leaders, consistent with its Williston Basin concentration carrying a modest discount to the Permian-exposed names.
With earnings on November 4, the question shifts to whether the production recovery from the Q1 trough, and the capital efficiency gains from extended 3- and 4-mile laterals, show up clearly enough in the print to validate the target upgrades. The short rebuild over the past month is the counterweight to watch.
See the live data behind this article on ORTEX.
Open CHRD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
